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Abstract
Background: Evidence from high income countries shows mothers who are supplemented with folic acid in their periconceptional
period and early pregnancy have significantly reduced adverse outcomes like birth defects. However, in India there is a paucity
of data on association of birth defects and folic acid supplementation. We identified a few important questions to be answered
using separate scientific methods and then planned to triangulate the information.
Objective: In this paper, we describe the protocol of our study that aims to determine the association of folic acid and pregnancy
outcomes like neural tube defects (NTDs) and orofacial clefts (OFCs). We decided to fill the gaps in knowledge from India to
determine public health consequences of folic acid deficiency and factors influencing dietary and periconceptional consumption
of folic acid.
Methods: The proposed study will be carried out in five stages and will examine the questions related to folic acid deficiency
across selected locations in South and North India. The study will be carried out over a period of 4 years through the hierarchical
evidence-based approach. At first a systematic review was conducted to pool the current birth prevalence of NTDs and orofacial
clefts OFCs in India. To investigate the population prevalence, we plan to use the key informant method to determine prevalence
of NTDs and OFCs. To determine the normal serum estimates of folic acid, iron, and vitamin B12 among Indian women (15-35
years), we will conduct a population-based, cross-sectional study. We will further strengthen the evidence of association between
OFCs and folic acid by conducting a hospital-based, case-control study across three locations of India. Lastly, using qualitative
methods we will understand community and health workers perspective on factors that decide the intake of folic acid supplements.
Results: This study will provide evidence on the community prevalence of birth defects and prevalence folic acid and vitamin
B12 deficiency in the community. The case-control study will help understand the association of folic acid deficiency with OFCs.
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Conclusions: The results from this study are intended to strengthen the evidence base in childhood disability for planning and
policy initiatives.
(JMIR Res Protoc 2016;5(2):e129)   doi:10.2196/resprot.5722
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Introduction
Background
Folic acid is a micronutrient with a vital role during human
reproduction and in a variety of physiological processes [1,2].
A report from the World Health Organization [3] indicated that
the percentage of pregnant women with a serum folic acid level
less than 3 ng/mL was highest among pregnant women in Sri
Lanka (57%), followed by India (41.6%). Poor serum folic acid
levels are linked with negative health outcomes in pregnancy
like abruptio placentae, preeclampsia, spontaneous abortion,
congenital heart defects, stillbirth, preterm delivery, low birth
weight, and serious birth defects of the brain and spine [4].
Studies from developed countries have shown folic acid
deficiency is strongly associated with birth defects, particularly
neural tube defects (NTDs) and orofacial clefts (OFCs) [1,5].
Evidence from some countries shows that mothers who are
supplemented with folic acid in their periconceptional period
and early pregnancy have significantly reduced adverse
outcomes compared with mothers who are not similarly
supplemented [6].
The review of the 4th Millennium development goal (reduce
child mortality) shows that the global under-5 child mortality
has drastically dropped by more than half [7]. In India, the
current under-5 child mortality is estimated to be 48 per 1000
live births, a little over the set target [8]. However, this decline
is attributed to a fall in the number of deaths from infectious
diseases and malnutrition; while the mortality attributed to birth
defects remains constant [9]. The most common birth defects
in India are NTDs [8]. OFCs are also an important birth defect
in India.
There are currently no large studies from India that report the
normal folate levels among Indian women and periconceptional
dietary consumption or supplementation of folic acid. The
periconceptional folic acid supplementation is challenging to
incorporate in the national programs. In the absence of baseline
evidence, planning and monitoring will be difficult. There are
no large studies on knowledge of folic acid and its importance
among laypersons in India. Only one small study demonstrates
that the awareness is poor, 10 of 50 women knew of folic acid,
and none of them linked it with birth defects [10]. Studies have
also shown that awareness among health providers about
periconceptional supplements is inadequate [11,12], while many
physicians were generally aware of the linkage between folic
acid and birth defects, their knowledge of timing and dosage
was found to be lacking.
India also does not have evidence for population prevalence of
NTDs or OFCs and association of low folic acid levels and birth
defects. India is one of the many countries of the world where
population estimates of the prevalence of birth defects are not
routinely collected [13]. Currently, there is no national registry
for birth defects. Hospital-based surveys or studies are the most
common source of information on birth defects like NTDs and
OFCs in India. These studies have reported inconsistent results.
We conducted a systematic review to determine the current birth
prevalence of NTDs and OFCs in India [14]. Our review
revealed that there was just one population-based study reporting
prevalence of NTDs from a rural district of North India [15].
There have been no population-based, high-quality studies
reporting prevalence of NTDs and OFCs from South India. The
review also pointed out significant regional differences in pooled
prevalence of both NTDs and OFCs [14].
The only population-based prevalence study from North India
used the door-to-door survey method to identify cases of NTDs
[15]. A door-to-door survey is time consuming and expensive
[16]. The key informant method (KIM) [17] may be a faster
and more cost-effective method to estimate population
prevalence’s. KIM has been successfully used in the past in
identifying children with disabilities in various low- and
middle-income countries like Bangladesh, China, Ethiopia, Iran,
Malawi, and Nigeria [18-26]. In India, only a few studies have
considered Integrated Child Development Service (Anganwadi)
workers and other community-based personnel as key informants
(KIs) to identify childhood disability [27,28].
We decided to fill the gaps in knowledge from India to
determine public health consequences of folic acid deficiency
and factors influencing dietary and periconceptional
consumption of folic acid. We identified a few important
questions to be answered using separate scientific methods and
then we plan to triangulate the information. To investigate the
population prevalence and to capture regional differences, we
plan to carry out a population-based prevalence study of birth
defects (NTDs and OFCs) in a rural community of South India
and urban community from North India using KIM. As a part
of the prevalence study, we will elicit history of specific dietary
practices and folic acid intake during the affected pregnancy.
This will provide evidence on association between dietary folic
acid and birth defects. We will also conduct a population-based,
cross-sectional study among women in the reproductive age
group (15-35 years) in South India, to determine normal serum
estimates of folic acid, iron, and vitamin B12.
A review of literature on association of folic acid and OFCs
shows there is some suggestive evidence for the role of folic
acid in prevention of OFCs [29]. However, the observational
case-control studies conducted so far have limitations of recall
bias and biased report of use based on the pregnancy outcome
of OFCs [29]. Yet, many studies have shown that knowledge
about consuming folic acid periconceptionally among women
is poor [30-34]. To build on the evidence gathered in our study,
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we will conduct a hospital-based, case-control study to look at
the association between folic acid deficiency during pregnancy
and OFCs. We are not including NTDs in the case-control study
as the child survival until 4 months of age is very low [35]. In
order to prevent recall bias, we will be eliciting history of folic
acid intake and dietary practices among cases within 4 months
of birth and from controls within 48 hours of birth. One
case-control study has been previously conducted in India, and
shows no significant association between the serum folate levels
of mothers of children with or without clefts [36]. However, in
this study, cases were included until the age of 14 months, by
which time the maternal folate levels would have fluctuated as
well as recall bias would have set in. The sample size of this
study was very small with just 28 cases of nonsyndromic clefts.
In order to triangulate the information, we will conduct a
qualitative study to determine the community and the health
provider's perspective to the factors that decide the intake of
folic acid supplements, and the health-seeking behavior among
pregnant women in the community.
Study Aim
The aim of this study is to determine the public health
consequences of folic acid deficiency among mothers in India.
Also, to study the association of folic acid deficiency with
pregnancy outcomes especially NTDs and OFCs.
Ethical Approval
The ethics committee of the Public Health Foundation of India
(TRC-IEC-117/11) has granted favorable ethical approval for
this study. Ethical approval was obtained in June 2012.
Methods
Design
The research proposed in five stages will examine the questions
related to folic acid deficiency across selected locations in South
and North India and its related consequences through the
hierarchical evidence-based approach. The overall study duration
will be 4 years. All data will be archived in an anonymized
format at the end of the study and will be password protected
to ensure that access is restricted to the investigators. Table 1
shows an overview of the five stages of this study with the
expected outcome and analysis plan.
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Table 1. Overview of study stages.
Analysis planExpected outcomeTools usedStudy loca-
tion
Study
method
Stage
Meta-analysis using Review
manager. Random and fixed- ef-
fect model to calculate pooled
prevalence
Birth prevalence of NTDs and
OFCs in India
Review managerIndiaSystematic
review
Stage 1
Database will be developed in
MS Access. STATA 14.0 will be
used for analysis
Population prevalence of NTDsb,
OFCsc, microcephaly, hydro-
cephalus, visual impairment,
hearing impairment, motor im-
pairments and intellectual impair-
ments among children less than
6 years of age
Prevalence of stillbirths in the
community
Descriptive statistics
Flip book for training KIsa, KI
profile, line listing format, and
semistructured questionnaire for
cases on: sociodemography, ante-
natal, intrapartum history, and
life style behavior
Mahbubna-
gar district,
Telangana
and North
east Delhi
Quantitative/
prevalence
study
Stage 2
Analysis of blood sample by sol-
id phase radioimmunoassay
method
Normative values for serum folic
acid, ferritin and vitamin B-12
among women in 15 to 35 years
age group
Body mass index of women in
the age group 15 to 35 years
Prevalence of folic acid and Vita-
min B12 deficiency
Hemoglobin estimation
Semistructured questionnaire on
sociodemographic and reproduc-
tive history, and blood samples;
anthropometric measurements
Mahbubna-
gar district,
Telangana
Estimation
of serum
folic acid,
ferritin and
vitamin B12
levels
Stage 3
Computer assisted thematic
analysis (Atlas-Ti software)
Community perspectives on
NTDs and OFCs
Sociocultural factors that affect
the uptake of folic acid supple-
ments
Health-seeking behavior during
pregnancy
Attitudes on periconceptional
folic acid supplementation
National Program and policy
perspectives from experts
Topic guide for focus group dis-
cussions, semistructured question-
naire for case studies, and inter-
view schedule for in-depth inter-
views
Mahbubna-
gar district,
Telangana
Qualitative
study
Stage 4
STATA 14.0 will be used for
analysis, and calculation of odds
ratio
Association between folic acid
supplementation and OFCs
Semistructured questionnaire on
sociodemographics, reproduc-
tive, medical, occupational histo-
ry and consumption of pericon-
ceptional folic acid supplements
Hyderabad
Bangalore
and Delhi
Case control
study- hospi-
tal based
Stage 5
aKey informants.
bNeural tube defects.
cOrofacial clefts.
Stage 1: Systematic Review
At the outset, a systematic review was conducted to summarize
the existing research evidence on the prevalence of NTDs and
OFCs among live births and stillbirths in India using data from
all available community- and hospital-based observational
studies [14]. A comprehensive literature search for observational
studies was conducted on MEDLINE and EMBASE databases
using medical subject heading terms (neural tube defects OR
cleft lip OR cleft palate AND prevalence AND India). We
included all hospital- or community-based studies determining
the birth prevalence of OFCs or NTDs. Nineteen studies met
our inclusion criteria, with only one community-based study.
Subgroup analysis was performed for region, time period,
consanguinity, and gender of newborn.
Meta-analysis was performed using Review Manager software.
We obtained a pooled birth prevalence of 4.5 per 1000 total
births (95% confidence interval [CI] 4.2-4.9) for NTDs and 1.3
per 1000 total births (95% CI 1.1-1.5) for OFCs using the
random-effect model. There was a significant variation in the
prevalence of both NTD and OFCs across regions of India [14].
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Stage 2: Population Prevalence study (KIM)
Objectives
1. To estimate the prevalence of specific birth defects: NTDs,
OFCs, microcephaly, hydrocephalus, visual impairment, hearing
impairment, motor impairment (cerebral palsy, club foot,
muscular dystrophy, poliomyelitis, phocomelia), and still births
among children less than 6 years of age in the community using
the KIs and health workers in Mahbubnagar district (Telangana)
and Northeast Delhi (Delhi)
2. To determine the proportion of disability caused by OFCs
and NTDs among all the specified birth defects in children less
than 6 years in Mahbubnagar district (Telangana) and Northeast
Delhi (Delhi)
3. To assess whether key informants can identify birth defects
that are visible to the naked eye
4. To describe epidemiological characteristics (maternal
characteristics such as age, parity, consumption of folic acid
supplements, residence, etc) of specified birth defects in
Mahbubnagar district (Telangana) and Northeast Delhi (Delhi).
Study Population
Children in the age group 0 to 6 years (born between 2008 and
2013), both live and stillbirths with any birth defect will be
recruited in the study. The respondent will be the mother of the
child. If she is not present (unavailable inspite of three visits or
dead), the child will be included in prevalence but will not be
recruited for eliciting the detailed history.
Sample Size and Study Sites
We used a combined prevalence of NTDs and OFCs of 10 per
10,000 births [37,38], 20% precision and alpha of 0.1 to estimate
the sample size. We calculated a total sample size of 44,824 for
the study. We plan to include two regions of India to conduct
the community-based prevalence study. One site is in North
India (Delhi) and the other in South India (Telangana).
Purposive sampling has been used to identify our study sites
within the two states. In Telangana, we have included seven
rural mandals (smallest administrative unit) of Mahbubnagar
district (Addakal, Bhoothpur, Bijinapalle, Jadcherla, Ghanpur,
Mahbubnagar (rural), and Thimmajipet). As per Census 2011,
the total population of these seven mandals is 355,043 [39] and
the population of children aged 0 to 6 years is 48,016 [40].
In Delhi, we have included seven urban regions from Northeast
Delhi (Shahadra, Seemapuri, Seelampur, Babarpur, Gautam
vihar, Wazirabad, and Anand mansarovar). The total population
from these seven regions is 335,805 [39] and the population of
children aged 0 to 6 years is 38,407 [41].
Study Design
The KIM [17] will be used to identify children (0-6 years) with
birth defects in the community. The KIs will be Anganwadi
workers, Accredited Social Health Activist, members of
Disabled Peoples Organization, and self-help groups from within
the study sites. We will recruit one KI for every 1000 population.
The KIs will undergo a 1-day training on identification of
specific birth defects among children: NTDs, OFCs,
microcephaly, congenital hydrocephalus, visual impairment,
hearing impairment, motor impairment (cerebral palsy, clubfoot,
muscular dystrophy, poliomyelitis, and phocomelia), and
intellectual impairment. Using a flipbook and a PowerPoint
presentation, our research team will conduct the training. We
are training the KIs on identifying birth defects other than NTDs
and OFCs so that we can determine the proportion of children
with NTDs and OFCs among all the visible birth defects in the
community.
The flipbook consists of 60 images depicting the various birth
defects mentioned above. The flipbook also consists of images
depicting foods rich in folic acid, images of folic acid tablets
and ways to prevent NTDs, OFCs, and other birth defects. From
each administrative region (approximately 100,000 population),
two to three batches of 20 to 22 KIs will be trained. The flipbook
has been pretested in the community and changes incorporated
in the images to make it culturally appropriate. The flipbook is
for training purposes only and will not be given to KIs for use
in the field. The pictures in the flipbook are thought to be
disturbing if showed to the layman in the field. However,
sketches of all the disabilities will be provided in a handout for
their reference in the field.
The KIs will do line listing for the 1000 population in which
she usually caters her community services too. The KIs will be
given 2 weeks to complete listing of cases of birth defects and
stillbirths from their specified population, after the training is
completed. The completed line listing forms will be handed
over to the field investigator, who will confirm and verify the
addresses of all the children listed. After the listing is completed,
a trained medical doctor will visit each of these children’s homes
and examine them to confirm the diagnosis. Written informed
consent will be obtained from the mother for examining the
child. For all the confirmed cases of specified birth defects, the
field investigator will document sociodemographic-, pregnancy-,
and birth-related history and risk factors using a prestructured
questionnaire from the mother of the affected child.
The mother of each child identified with birth defects will also
be asked if she is aware of any other child with a similar birth
defect in the vicinity. This will help in identifying any case,
which may have been missed by the KI. In order to triangulate
the data, a list of children with birth defects will be obtained
from the Society for Elimination of Rural Poverty in Telangana
and Smile Train Project. This will be used to compare and
identify the missed cases if any.
Prevalence will be calculated as the number of cases of birth
defect identified in the district using the KIM divided by the
estimated number of children (0-6 years) alive in that district
as per the Census data.
Statistical Analysis
A database will be developed in MS ACCESS. STATA 14.0
will be used for data analysis.
Stage 3: Estimation of Serum Folic Acid, Ferritin, and
Vitamin B-12
This study is being conducted in association with National
Institute of Nutrition (NIN) at Hyderabad. It is part of a
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concurrent study at NIN looking at the nutritional status of
women in the age group 15 to 35 years of age in Mahbubnagar
district of Telangana.
Objective
1. To estimate normative values of serum folic acid, ferritin,
and vitamin B12 among women in the age group 15 to 35 years
in Mahbubnagar district, Telangana
2. To estimate the prevalence of folic acid and vitamin B-12
deficiency among 15 to 35 years women in the community
(Mahbubnagar district, Telangana).
Sample Size and Study Site
For calculating the sample size, we used unpublished data from
NIN on mean folic acid levels and standard error for women in
the reproductive age group. Using the mean folic acid level of
10 ng/mL and standard error of 1.1, and a precision of 0.1 and
0.05 alpha, we calculated a sample size of 465. Thus, for this
study, we will recruit 500 women in the reproductive age (15-35
years) from Mahbubnagar district, Telangana.
Study Design
This is a community-based, cross-sectional study. Women in
the age group 15 to 35 years, irrespective of their marital,
pregnancy, and lactation status, will be recruited in the study.
Written informed consent will be obtained from the participants
before registering and conducting any interview or blood
examination. Any woman who is seriously ill or refuses to
participate will be excluded from the study. A multistage,
stratified, two-stage, random sampling method will be used. To
get a representative sample, we will randomly select one mandal
from each revenue division of the Mahbubnagar district. Thus,
five mandals will be randomly selected. From each mandal,
three villages will be randomly selected. Within each selected
village, we will randomly select 30 to 35 households with
women 15 to 35 years. From each household, only one woman
will be randomly selected for the study.
The field investigator will administer a semistructured
questionnaire eliciting sociodemographic and reproductive
history and take anthropometric measurements. A trained lab
technician will then draw 5 to 10 mL of blood from the
participants under aseptic conditions. The blood sample will be
centrifuged in the field, within 6 hours and stored at −20° C in
a laboratory in the mandal. The samples will be transported to
NIN, Hyderabad thrice a week for analysis.
At NIN, plasma levels of vitamin B12 and folic acid will be
measured by solid phase radioimmunoassay method using a
commercially available kit designed for simultaneous
measurement of vitamin B12, ferritin and folic acid [42].
Hemoglobin estimation will be done. We will estimate the
prevalence of folic acid and vitamin B12 deficiency among the
women.
Statistical Analysis
The data will be analyzed using SPSS and a normogram will
be plotted. The mean and median level of folic acid, ferritin,
and vitamin B12 levels will be ascertained. Appropriate
adjustments for potential confounder effects will be made.
Stage 4: Community and Program Perspectives on
NTDS, OFCs, and Periconceptional Folic Acid
Supplementation
Objectives
1. To explore community perspectives among both men and
women, on birth defects like NTDs and OFCs, using case studies
and focus group discussions (FGDs) in Mahbubnagar district,
Telangana
2. To examine sociocultural factors and their effect on uptake
of folic acid supplementation during the periconceptional period
by using interviews with health care staff in Mahbubnagar
district, Telangana
3. To examine program perspectives on periconceptional folic
acid supplementation by using in-depth interviews (IDIs) among
personnel working in National program against anemia.
Study Design
This is a qualitative study. Data for this aspect of the study will
be collected through a mix of qualitative data collection tools
such as FGDs, IDIs, and case studies. In order to get a holistic
picture of the knowledge and perceptions of NTDs and OFCs
and the link of these with folic acid, data will be collected from
the community as well the health system. Then the results will
then be triangulated.
Study Site
The study will be conducted in the four Mandals of
Mahbubnagar district of Telangana. These mandals have been
purposively chosen to cover a diverse population that is
depictive of the natural setting in this region: Bijinapalle
(majority population is Scheduled caste and tribes), Jadcherla
(majority tribal population), Mahbubnagar (predominantly
Muslim population with easy access to health care), and Ghanpur
(predominantly Muslim population with poor access to health
care).
Sampling and Data Collection Methods
For objectives 1 and 2, data will be collected from the
community using FGDs and case studies. Because some of the
themes are gender-sensitive, FGDs will be conducted separately
with men and women. The FGDs are intended to elicit
community perceptions on local ideas of causation, prevention,
and treatment of NTDs and OFCs. FGDs with women also
include themes on practices during pregnancy and childbirth
that might have repercussions on NTDs/OFCs.
The composition of persons participating in the FGDs will be
purposively selected. The study population we cover includes
a mix of scheduled castes, tribes, Muslim minorities, and persons
who reside in the semiurban regions. We intend to conduct
discussions with each of these four groups. An indicative number
of FGDs in each of the mandals is given in Table 2. The
principle of data saturation will be used to guide the actual
number of FGDs conducted.
In addition to the FGDs with the community, we will be doing
individual interviews (case studies) with families having affected
children and with affected adults. Here, we chose to do
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interviews because we felt that responses to certain questions
such as stigma, testing, and ways through which the disease
affects their life, may be personal and people may be hesitant
to share such ideas in a group. The participants for case studies
will also be purposively chosen so as to elicit rich and illustrative
perspectives on themes such as living with OFCs, coping with
a child having NTDs/OFCs, stigma in different stages of live,
gender differences in coping, and access to care. We intend to
do approximately 10 to 15 case studies in the four mandals.
For objective 2, we will be collecting data through IDIs with
health system staff including doctors, nurses, auxiliary nurse
midwife (ANM), and other community level workers. These
interviews will help us understand issues pertinent to the
knowledge of NTDs/OFCs among health workers and issues
with the supply of folic acid and its supplementation. Here, we
choose the interview method over FGDs due to the logistic
difficulties in getting health system staff together in one place.
We will supplement this information with data from interviews
with personnel working in the National program against anemia
(objective 3). Overall, this set of interviews will help us envisage
barriers to the supplementation of folic acid from the perspective
of the health system; and the feasibility of a periconceptional
folic acid program in India. All interviews will be conducted in
the local language (Telugu and Deccani Hindi). Table 2 gives
an indicative number of the number of interviews to be
conducted within the health system; the concept of data
saturation will be used to guide the actual numbers.
Table 2. Data collection for qualitative study (indicative numbers).
Case StudiesFocus group discus-
sions
Focus group discus-
sions
In-depth interviewsIn-depth interviews
Type of population
Families with affected chil-
dren/Adults with
NTDa/OFCb
Community (women
in reproductive age
group)
Community (Gener-
al)
Experts and person-
nel in National ane-
mia program
Health system
Name of mandal
Scheduled Tribe -1
Scheduled Caste -2
Scheduled Tribe- 1
Scheduled Caste-2
Doctor -3
Nurse-3
ANMc/ASHAd- 6
Bijinapalle
Scheduled Tribe-2Scheduled Tribe -2Doctor -1
Nurse-1
ANM/ASHA- 2
Jadcherla
Muslim-1
Semiurban-2
Muslim-1
Semiurban-2
Doctor -1
Nurse-1
ANM/ASHA- 2
Mahbubnagar
Muslim-1Muslim-1Doctor -2
Nurse-2
ANM/ASHA- 4
Ghanpur
Total
To choose depending on
number/ type of cases from
the KIe study –approximate-
ly 10-15
8 FGDs8 FGDsAs required (5-10)Doctor -7
Nurse-7
ANM/ASHA- 14
aNeural tube defects.
bOrofacial cleft.
cAuxiliary nurse midwife.
dAccredited social health activist.
eKey informant.
Data Analysis
Data analysis for this study will be initiated concurrently with
the data collection process, so as to allow the team to refine the
questions, develop hypothesis, and pursue emerging avenues
of inquiry for IDIs subsequently. All the FGDs, case studies,
and IDIs will be translated into English and transcribed. Generic
thematic analysis techniques will be used for the study. Analyses
will be initiated with a list of predefined themes and new themes
will be incorporated as these emerge. For data reduction, the
qualitative analysis software ATLAS-TI will be used.
Stage 5: Case Control Study (Hospital-Based)
Objectives
The objective is to determine if mothers of children with OFCs
are more likely to have folic acid deficiency during the
periconceptional period and early pregnancy (first trimester) in
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hospital-based settings in Delhi, Hyderabad, and Bangalore. In
order to prevent recall bias among the respondents, we will be
eliciting history of folic acid intake and dietary practices among
cases within 4 months of birth and from controls within 48 hours
of birth. In this study, we did not include NTDs, as it was not
logistically feasible to capture cases at the time of birth. If we
increased the case population to less than 4-months old then
due to high mortality of NTDs we will not get the required
sample size.
Sample Size and Study Site
In terms of power and sample size, it is estimated with 90%
power assumed to detect a 50% increase in risk (odds ratio=1.5)
associated with a risk factor (periconceptional folic acid intake)
present in the controls group at a prevalence of approximately
20% and assuming nonresponse rate of 5%. The required sample
size would be 150 cases and 600 controls. Hence, this total
sample size will be recruited cumulatively from three sites.
Study Design (Recruitment of Cases and Controls)
This is a hospital-based case control study that will be conducted
simultaneously in three cities of India: Hyderabad, Delhi, and
Bangalore. From each city, we will select two treatment centers
and two delivery centers (hospitals). The cases and controls will
be recruited over a period of 6 months from each site.
Any child with cleft lip with or without cleft palate or only cleft
palate visiting the hospital for treatment (treatment center) within
4 months of birth will be recruited in the study. Clefts may occur
in the lip, the roof of the mouth (hard palate), or the tissue at
the back of the mouth (soft palate). The mother of this child
will be considered as a case. Cases will be recruited only if they
belong to the catchment area of the hospital. We will define the
catchment area of the hospital by reviewing the statistics of the
previous years. Controls will be matched based on the parity of
the mother (primigravida or multigravida).
Controls will be recruited from the maternity hospitals (delivery
centers) nearby to the treatment centers with a delivery load of
10,000 deliveries. Also, district level tertiary hospitals
(government) will be considered for recruitment of controls.
Controls will be recruited and interviewed within 48 hours of
the birth of the baby.
A researcher will be stationed round the clock at the treatment
and recruitment centers in all the three cities. They will recruit
a case only after the physician has confirmed the diagnosis.
Textbox 1. Inclusion and exclusion criteria for the selection of cases.
Inclusion criteria
• Mothers of babies born with nonsyndromic OFCs
• Mothers of babies visiting the treatment center within 4 months of birth of baby and from the center’s catchment area
Exclusion criteria
• Not belonging to treatment center’s catchment area
• Syndromic cases of OFCs
• Mothers who are currently a part of another ongoing research study receiving any intervention
Textbox 2. Inclusion and exclusion criteria for the selection of controls.
Inclusion criteria
• Mother of babies born at the delivery center and from the same geographical location
• Mother of a live birth without any birth defect
Exclusion criteria
• Mothers who are currently a part of any other ongoing research study receiving any intervention
• Any maternal complication that requires immediate emergency care
Study Tool
A semistructured questionnaire will be administered to cases
and controls by our research team. This will gather details on
sociodemographic aspects and details of reproductive, medical,
and occupational history.
The primary exposure for the study is folic acid consumption
in the periconceptional period in a mother. History of intake of
folic acid tablets during the periconceptional period and dietary
history would help elicit the exposure status. Other exposures
likely to be associated with OFCs, such as intake of drugs during
pregnancy, sex selection practices, and exposure to pesticides
would be elicited from history.
Statistical Analysis
A database will be developed in MS Access. Data analysis will
be done using STATA 14.0. Descriptive and inferential statistics
output will be generated. The prevalence of exposure will be
compared between cases and controls using logistic regression,
adjusting for potential confounder effects as appropriate.
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Results
This research was supported by a Wellcome Trust Capacity
Strengthening Strategic Award to the Public Health Foundation
of India and a consortium of United Kingdom universities. The
results from the individual studies will be available between
2016 and 2017.
Discussion
Trial Implications
This paper outlines the rationale and design of a multistage
study including a systematic review determining the current
trends in birth prevalence of OFCs and NTDs across India,
followed by a cross-sectional, population-based study to
determine prevalence of specified birth defects and deficiency
of folic acid and vitamin B12 in the community and by a case
control study to study association of folic acid deficiency with
OFCs. The outcomes from this study will help inform the
research community about the feasibility of involving grass root
level functionaries for screening cases of OFCs and NTDs.
We anticipate certain challenges in conducting this study.
Identification of some of these is likely to be an intermediate
outcome of this study as well as help in addressing the
challenges involved in implementation of national programmes
for early identification and early intervention.
Challenges
Birth defects being considered a social taboo in India, we may
have difficulty in getting mothers to participate in the study.
Also, the prevalence of some of the specified birth defects is
low and it may be difficult to identify these children in the
community. For the case control study, it may be very difficult
to get cooperation from the cases, as they may want to tend to
the child. The deliverables and the outcomes from this research
will drive strategies in minimizing the adverse public health
consequences of folic acid deficiency among mothers in India
and strengthen the evidence base in childhood disability for
planning and policy initiatives.
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